研究论文开放获取
The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort study
Deniz Can Güven, Emre Yekedüz, Enes Erul, Satı Coşkun Yazgan, Taha Koray Şahin, Göktürk Karataş, Sercan Aksoy, Mustafa Erman 等 11 位
Hacettepe University Hospital Hacettepe University Ankara University Memorial Ankara Hospital
来源Journal of Cancer Research and Clinical Oncology
年份2022
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
摘要 · 节选
暂未获取摘要。可打开原文或 PDF，后续可基于全文生成更完整的速读。
逐年被引趋势
210
223
24
25
关键指标
6
被引次数 · OpenAlex
0.56
领域内被引倍数
同类平均 = 1
同类平均 = 1
前 34%
引用位次
同领域 · 同年份 · 同类型
同领域 · 同年份 · 同类型
55
参考文献
Google Scholar 与 OpenAlex 的被引统计范围不同，数值存在差异属正常。
AI 辅助阅读
依据：文献信息
论文问答
当前基于文献信息回答
可就本文提问；依据不足时会说明。
学术脉络
学科主题
生物医学Cancer Immunotherapy and Biomarkers
Lung Cancer Diagnosis and Treatment · Hepatocellular Carcinoma Treatment and Prognosis
参考文献 55
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
被引 29,890E. Eisenhauer, P. Therasse, Jan Bogaerts · European Journal of Cancer · 2008
Third-Line Chemotherapy in Advanced Non-small Cell Lung Cancer: Identifying the Candidates for Routine Practice
被引 71Nicolas Girard, P. Jacoulet, M Gainet · Journal of Thoracic Oncology · 2009
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
被引 3,026Robert J. Motzer, Bernard Escudier, Stéphane Oudard · The Lancet · 2008
此处列出前 3 条
引用本文 6
Early thrombocytopenia predicts longer time‑to‑treatment discontinuation in trastuzumab emtansine treatment
被引 8Ahmet Bilgehan Şahin, Burcu Caner, Birol Ocak · Oncology Letters · 2023
Descriptions of advanced multimorbidity: A scoping review with content analysis
被引 6Sarah Bowers, Polly Black, Lewis McCheyne · Journal of Multimorbidity and Comorbidity · 2025
Concomitant Immunotherapy and Metastasis-Directed Radiotherapy in Upper Tract Urothelial Carcinoma: A Biomarker-Driven, Original, Case-Based Proof-of-Concept Study
被引 5Gaetano Pezzicoli, Francesco Salonne, Vittoria Musci · Journal of Clinical Medicine · 2023
按被引量排序，此处列出前 3 条